The Role of PAX2 in Neurodevelopment and Disease

References

• Mateus-Pinheiro A, Alves ND, Patrício P, et al. AP2γ controls adult hippocampal neurogenesis and modulates cognitive, but not anxiety or depressive-like behavior. Mol Psychiatry. 2017;22(12):1725–1734. doi:10.1038/mp.2016.16927777416
   PubMed Web of Science ®Google Scholar
• Teixeira JR, Szeto RA, Carvalho VMA, Muotri AR, Papes F. Transcription factor 4 and its association with psychiatric disorders. Transl Psychiatry. 2021;11(1):19. doi:10.1038/s41398-020-01138-033414364
   PubMed Web of Science ®Google Scholar
• Estruch SB, Graham SA, Quevedo M, et al. Proteomic analysis of FOXP proteins reveals interactions between cortical transcription factors associated with neurodevelopmental disorders. Hum Mol Genet. 2018;27(7):1212–1227. doi:10.1093/hmg/ddy23029365100
   PubMed Web of Science ®Google Scholar
• Wegmann S, DeVos SL, Zeitler B, et al. Persistent repression of tau in the brain using engineered zinc finger protein transcription factors. Sci Adv. 2021;7(12):eabe1611. doi:10.1126/sciadv.abe161133741591
   PubMed Web of Science ®Google Scholar
• Hwang JY, Zukin RS. REST, a master transcriptional regulator in neurodegenerative disease. Curr Opin Neurobiol. 2018;48:193–200. doi:10.1016/j.conb.2017.12.00829351877
   PubMed Web of Science ®Google Scholar
• Whitton L, Apostolova G, Rieder D, et al. Genes regulated by SATB2 during neurodevelopment contribute to schizophrenia and educational attainment. PLoS Genet. 2018;14(7):e1007515. doi:10.1371/journal.pgen.100751530040823
   PubMed Web of Science ®Google Scholar
• Rossanti R, Morisada N, Nozu K, et al. Clinical and genetic variability of PAX2-related disorder in the Japanese population. J Hum Genet. 2020;65(6):541–549. doi:10.1038/s10038-020-0741-y32203253
   PubMed Web of Science ®Google Scholar
• Cheong HI, Cho HY, Kim JH, Yu YS, Ha IS, Choi Y. A clinico-genetic study of renal coloboma syndrome in children. Pediatr Nephrol. 2007;22(9):1283–1289. doi:10.1007/s00467-007-0525-z17541647
   PubMed Web of Science ®Google Scholar
• O’Rahilly R, Müller F. Developmental stages in human embryos: revised and new measurements. Cells Tissues Organs. 2010;192(2):73–84. doi:10.1159/00028981720185898
   PubMed Web of Science ®Google Scholar
• Vinci L, Ravarino A, Fanos V, et al. Immunohistochemical markers of neural progenitor cells in the early embryonic human cerebral cortex. Eur J Histochem. 2016;60(1):2563. doi:10.4081/ejh.2016.256326972711
   PubMed Web of Science ®Google Scholar
• Wefers AK, Wefers AK, Haberlandt C, et al. Migration of Interneuron Precursors in the Nascent Cerebellar Cortex. The Cerebellum. 2018;17(1):62–71. doi:10.1007/s12311-017-0900-729149443
   PubMed Web of Science ®Google Scholar
• Scherholz M, Redl E, Wollesen T, de Oliveira AL, Todt C, Wanninger A. Ancestral and novel roles of Pax family genes in mollusks. BMC Evol Biol. 2017;17(1):81. doi:10.1186/s12862-017-0919-x28302062
   PubMed Web of Science ®Google Scholar
• Namm A. Expression of Pax2 protein during the formation of the central nervous system in human embryos. Folia Morphol. 2014;73(3):272–278. doi:10.5603/FM.2014.0043
   Web of Science ®Google Scholar
• Thompson JA, Ziman M. Pax genes during neural development and their potential role in neuroregeneration. Prog Neurobiol. 2011;95(3):334–351. doi:10.1016/j.pneurobio.2011.08.01221930183
   PubMed Web of Science ®Google Scholar
• Larsson M. Pax2 is persistently expressed by GABAergic neurons throughout the adult rat dorsal horn. Neurosci Lett. 2017;638:96–101. doi:10.1016/j.neulet.2016.12.01527939388
   PubMed Web of Science ®Google Scholar
• O’Roak BJ, Stessman HA, Boyle EA, et al. Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun. 2014;5:5595. doi:10.1038/ncomms659525418537
   PubMed Web of Science ®Google Scholar
• Davis LK, Meyer KJ, Rudd DS, et al. Pax6 3ʹ deletion results in aniridia, autism and mental retardation. Hum Genet. 2008;123(4):371–378. doi:10.1007/s00439-008-0484-x18322702
   PubMed Web of Science ®Google Scholar
• Kikkawa T, Casingal CR, Chun SH, Shinohara H, Hiraoka K, Osumi N. The role of Pax6 in brain development and its impact on pathogenesis of autism spectrum disorder. Brain Res. 2019;1705:95–103. doi:10.1016/j.brainres.2018.02.04129499177
   PubMed Web of Science ®Google Scholar
• Lord C, Brugha TS, Charman T, et al. Autism spectrum disorder. Nat Rev Dis Primers. 2020;6(1):5. doi:10.1038/s41572-019-0138-431949163
   PubMed Web of Science ®Google Scholar
• Bower MA, Schimmenti LA, Eccles MR, et al. PAX2-Related Disorder. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews(^®). University of Washington, Seattle Copyright © 1993–2021; 2018: 154.
   Google Scholar
• Galvez-Ruiz A, Lehner AJ, Galindo-Ferreiro A, Schatz P. Three New PAX2 Gene Mutations in Patients with Papillorenal Syndrome. Neuroophthalmology. 2017;41(5):271–278. doi:10.1080/01658107.2017.130799529339962
   PubMed Web of Science ®Google Scholar
• Schimmenti LA. Renal coloboma syndrome. Eur J Hum Genet. 2011;19(12):1207–1212. doi:10.1038/ejhg.2011.10221654726
   PubMed Web of Science ®Google Scholar
• Cunliffe HE, McNoe LA, Ward TA, Devriendt K, Brunner HG, Eccles MR. The prevalence of PAX2 mutations in patients with isolated colobomas or colobomas associated with urogenital anomalies. J Med Genet. 1998;35(10):806–812. doi:10.1136/jmg.35.10.8069783702
   PubMed Web of Science ®Google Scholar
• Miyazawa T, Nakano M, Takemura Y, et al. A case of renal-coloboma syndrome associated with mental developmental delay exhibiting a novel PAX2 gene mutation. Clin Nephrol. 2009;72(6):497–500. doi:10.5414/cnp7249719954729
   PubMed Web of Science ®Google Scholar
• Deng H, Zhang Y, Xiao H, et al. Diverse phenotypes in children with PAX2‐related disorder. Mol Genet Genomic Med. 2019;7(6):e701. doi:10.1002/mgg3.70131060108
   PubMed Web of Science ®Google Scholar
• Yokoi T, Enomoto Y, Tsurusaki Y, et al. An efficient genetic test flow for multiple congenital anomalies and intellectual disability. Pediatr Int. 2020;62(5):556–561. doi:10.1111/ped.1415931955471
   PubMed Web of Science ®Google Scholar
• Sanyanusin P, Schimmenti LA, McNoe LA, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet. 1995;9(4):358–364. doi:10.1038/ng0495-3587795640
   PubMed Web of Science ®Google Scholar
• Schimmenti LA, Cunliffe HE, McNoe LA, et al. Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am J Hum Genet. 1997;60(4):869–878.9106533
   PubMed Web of Science ®Google Scholar
• Schimmenti LA, Shim HH, Wirtschafter JD, et al. Homonucleotide expansion and contraction mutations ofPAX2 and inclusion of Chiari 1 malformation as part of Renal-Coloboma syndrome. Hum Mutat. 1999;14(5):369–376. doi:10.1002/(SICI)1098-1004(199911)14:5<369::AID-HUMU2>3.0.CO;2-E10533062
   PubMed Web of Science ®Google Scholar
• Benetti E, Artifoni L, Salviati L, et al. Renal hypoplasia without optic coloboma associated with PAX2 gene deletion. Nephrol Dial Transplant. 2007;22(7):2076–2078. doi:10.1093/ndt/gfm18717403695
   PubMed Web of Science ®Google Scholar
• Deutsch U, Dressler GR, Gruss P. Pax 1, a member of a paired box homologous murine gene family, is expressed in segmented structures during development. Cell. 1988;53(4):617–625. doi:10.1016/0092-8674(88)90577-62453291
   PubMed Web of Science ®Google Scholar
• Stapleton P, Weith A, Urbánek P, Kozmik Z, Busslinger M. Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. Nat Genet. 1993;3(4):292–298. doi:10.1038/ng0493-2927981748
   PubMed Web of Science ®Google Scholar
• Krauss S, Johansen T, Korzh V, Fjose A. Expression pattern of zebrafish pax genes suggests a role in early brain regionalization. Nature. 1991;353(6341):267–270. doi:10.1038/353267a01680220
   PubMed Web of Science ®Google Scholar
• Goulding MD, Lumsden A, Gruss P. Signals from the notochord and floor plate regulate the region-specific expression of two Pax genes in the developing spinal cord. Development. 1993;117(3):1001–1016. doi:10.1242/dev.117.3.10018100762
   PubMed Web of Science ®Google Scholar
• Walther C, Guenet JL, Simon D, et al. Pax: a murine multigene family of paired box-containing genes. Genomics. 1991;11(2):424–434. doi:10.1016/0888-7543(91)90151-41685142
   PubMed Web of Science ®Google Scholar
• Dahl E, Koseki H, Balling R. Pax genes and organogenesis. Bioessays. 1997;19(9):755–765. doi:10.1002/bies.9501909059297966
   PubMed Web of Science ®Google Scholar
• Lechner MS, Dressler GR. Mapping of Pax-2 transcription activation domains. J Biol Chem. 1996;271(35):21088–21093. doi:10.1074/jbc.271.35.210888702876
   PubMed Web of Science ®Google Scholar
• Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P. Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development. 1990;109(4):787–795. doi:10.1242/dev.109.4.7871977574
   PubMed Web of Science ®Google Scholar
• Ritz-Laser B, Estreicher A, Gauthier B, Philippe J. The paired homeodomain transcription factor Pax-2 is expressed in the endocrine pancreas and transactivates the glucagon gene promoter. J Biol Chem. 2000;275(42):32708–32715. doi:10.1074/jbc.M00570420010938089
   PubMed Web of Science ®Google Scholar
• Tavassoli K, Rüger W, Horst J. Alternative splicing in PAX2 generates a new reading frame and an extended conserved coding region at the carboxy terminus. Hum Genet. 1997;101(3):371–375. doi:10.1007/s0043900506449439670
   PubMed Web of Science ®Google Scholar
• Ward TA, Nebel A, Reeve AE, Eccles MR. Alternative messenger RNA forms and open reading frames within an additional conserved region of the human PAX-2 gene. Cell Growth Differ. 1994;5(9):1015–1021.7819127
   PubMedGoogle Scholar
• Rowitch DH, McMahon AP. Pax-2 expression in the murine neural plate precedes and encompasses the expression domains of Wnt-1 and En-1. Mech Dev. 1995;52(1):3–8. doi:10.1016/0925-4773(95)00380-j7577673
   PubMed Web of Science ®Google Scholar
• Frisen J, Johansson CB, Lothian C, Lendahl U. Central nervous system stem cells in the embryo and adult. Cell Mol Life Sci. 1998;54(9):935–945. doi:10.1007/s0001800502249791537
   PubMed Web of Science ®Google Scholar
• Schwarz M, Alvarez-Bolado G, Dressler G, Urbanek P, Busslinger M, Gruss P. Pax2/5 and Pax6 subdivide the early neural tube into three domains. Mech Dev. 1999;82(1–2):29–39. doi:10.1016/s0925-4773(99)00005-210354469
   PubMed Web of Science ®Google Scholar
• Fotaki V, Price DJ, Mason JO. Newly identified patterns of Pax2 expression in the developing mouse forebrain. BMC Dev Biol. 2008;8(1):79. doi:10.1186/1471-213X-8-7918700968
   PubMed Web of Science ®Google Scholar
• Pfeffer PL, Bouchard M, Busslinger M. Pax2 and homeodomain proteins cooperatively regulate a 435 bp enhancer of the mouse Pax5 gene at the midbrain-hindbrain boundary. Development. 2000;127(5):1017–1028. doi:10.1242/dev.127.5.101710662641
   PubMed Web of Science ®Google Scholar
• Pillai A, Mansouri A, Behringer R, Westphal H, Goulding M. Lhx1 and Lhx5 maintain the inhibitory-neurotransmitter status of interneurons in the dorsal spinal cord. Development. 2007;134(2):357–366. doi:10.1242/dev.0271717166926
   PubMed Web of Science ®Google Scholar
• Maricich SM, Herrup K. Pax-2 expression defines a subset of GABAergic interneurons and their precursors in the developing murine cerebellum. J Neurobiol. 1999;41(2):281–294. doi:10.1002/(sici)1097-4695(19991105)41:2<281::aid-neu10>3.0.co;2-510512984
   PubMed Web of Science ®Google Scholar
• Rhinn M, Brand M. The midbrain–hindbrain boundary organizer. Curr Opin Neurobiol. 2001;11(1):34–42. doi:10.1016/s0959-4388(00)00171-911179870
   PubMed Web of Science ®Google Scholar
• Favor J, Sandulache R, Neuhäuser-Klaus A, et al. The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney. Proc Natl Acad Sci U S A. 1996;93(24):13870–13875. doi:10.1073/pnas.93.24.138708943028
   PubMed Web of Science ®Google Scholar
• Schwarz M, Alvarez-Bolado G, Urbánek P, Busslinger M, Gruss P. Conserved biological function between Pax-2 and Pax-5 in midbrain and cerebellum development: evidence from targeted mutations. Proc Natl Acad Sci U S A. 1997;94(26):14518–14523. doi:10.1073/pnas.94.26.145189405645
   PubMed Web of Science ®Google Scholar
• Bouchard M, Pfeffer P, Busslinger M. Functional equivalence of the transcription factors Pax2 and Pax5 in mouse development. Development. 2000;127(17):3703–3713. doi:10.1242/dev.127.17.370310934015
   PubMed Web of Science ®Google Scholar
• Simon HH, Bhatt L, Gherbassi D, Sgadó P, Alberí L. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann N Y Acad Sci. 2003;991:36–47. doi:10.1111/j.1749-6632.2003.tb07461.x12846972
   PubMed Web of Science ®Google Scholar
• Niu Y, Moghimyfiroozabad S, Moghimyfiroozabad A. The factors for the early and late development of midbrain dopaminergic neurons segregate into two distinct evolutionary clusters. Brain Disorders. 2021;100002. doi:10.1016/j.dscb.2021.100002
   Google Scholar
• Borromeo MD, Meredith DM, Castro DS, et al. A transcription factor network specifying inhibitory versus excitatory neurons in the dorsal spinal cord. Development. 2014;141(14):2803–2812. doi:10.1242/dev.10586624924197
   PubMed Web of Science ®Google Scholar
• Leto K, Carletti B, Williams IM, Magrassi L, Rossi F. Different types of cerebellar GABAergic interneurons originate from a common pool of multipotent progenitor cells. J Neurosci. 2006;26(45):11682–11694. doi:10.1523/jneurosci.3656-06.200617093090
   PubMed Web of Science ®Google Scholar
• Fauquier T, Romero E, Picou F, et al. Severe impairment of cerebellum development in mice expressing a dominant-negative mutation inactivating thyroid hormone receptor alpha1 isoform. Dev Biol. 2011;356(2):350–358. doi:10.1016/j.ydbio.2011.05.65721621530
   PubMed Web of Science ®Google Scholar
• Huang M, Huang T, Xiang Y, et al. Ptf1a, Lbx1 and Pax2 coordinate glycinergic and peptidergic transmitter phenotypes in dorsal spinal inhibitory neurons. Dev Biol. 2008;322(2):394–405. doi:10.1016/j.ydbio.2008.06.03118634777
   PubMed Web of Science ®Google Scholar
• Chang JC, Meredith DM, Mayer PR, et al. Prdm13 mediates the balance of inhibitory and excitatory neurons in somatosensory circuits. Dev Cell. 2013;25(2):182–195. doi:10.1016/j.devcel.2013.02.01523639443
   PubMed Web of Science ®Google Scholar
• Guo Z, Zhao C, Huang M, et al. Tlx1/3 and Ptf1a control the expression of distinct sets of transmitter and peptide receptor genes in the developing dorsal spinal cord. J Neurosci. 2012;32(25):8509–8520. doi:10.1523/jneurosci.6301-11.201222723691
   PubMed Web of Science ®Google Scholar
• Mona B, Uruena A, Kollipara RK, et al. Repression by PRDM13 is critical for generating precision in neuronal identity. Elife. 2017;6:e25787. doi:10.7554/eLife.2578728850031
   PubMed Web of Science ®Google Scholar
• Lowenstein ED, Rusanova A, Stelzer J, et al. Olig3 regulates early cerebellar development. Elife. 2021;10:e64684. doi:10.7554/eLife.6468433591268
   PubMed Web of Science ®Google Scholar
• Wei H, Wang M, Lv N, et al. Increased repetitive self-grooming occurs in Pax2 mutant mice generated using CRISPR/Cas9. Behav Brain Res. 2020;393:112803. doi:10.1016/j.bbr.2020.11280332653558
   PubMed Web of Science ®Google Scholar
• Satterstrom FK, Kosmicki JA, Wang J, et al. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020;180(3):568–584.e23. doi:10.1016/j.cell.2019.12.03631981491
   PubMed Web of Science ®Google Scholar
• Sohal VS, Rubenstein JLR. Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol Psychiatry. 2019;24(9):1248–1257. doi:10.1038/s41380-019-0426-031089192
   PubMed Web of Science ®Google Scholar
• Di J, Li J, O’Hara B, et al. The role of GABAergic neural circuits in the pathogenesis of autism spectrum disorder. Int J Dev Neurosci. 2020;80(2):73–85. doi:10.1002/jdn.1000531910289
   PubMed Web of Science ®Google Scholar
• Yizhar O, Fenno LE, Prigge M, et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011;477(7363):171–178. doi:10.1038/nature1036021796121
   PubMed Web of Science ®Google Scholar
• Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem. 2006;98(3):641–653. doi:10.1111/j.1471-4159.2006.03913.x16787421
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD. Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum. 2009;8(1):64–69. doi:10.1007/s12311-008-0075-319002745
   PubMed Web of Science ®Google Scholar
• Oblak AL, Gibbs TT, Blatt GJ. Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism. J Neurochem. 2010;114(5):1414–1423. doi:10.1111/j.1471-4159.2010.06858.x20557420
   PubMed Web of Science ®Google Scholar
• Fung LK, Flores RE, Gu M, et al. Thalamic and prefrontal GABA concentrations but not GABA(A) receptor densities are altered in high-functioning adults with autism spectrum disorder. Mol Psychiatry. 2021;26(5):1634–1646. doi:10.1038/s41380-020-0756-y32376999
   PubMed Web of Science ®Google Scholar
• Puts NAJ, Wodka EL, Harris AD, et al. Reduced GABA and altered somatosensory function in children with autism spectrum disorder. Autism Res. 2017;10(4):608–619. doi:10.1002/aur.169127611990
   PubMed Web of Science ®Google Scholar
• Zapata J, Moretto E, Hannan S, et al. Epilepsy and intellectual disability linked protein Shrm4 interaction with GABA(B)Rs shapes inhibitory neurotransmission. Nat Commun. 2017;8:14536. doi:10.1038/ncomms1453628262662
   PubMed Web of Science ®Google Scholar
• Chuang SH, Reddy DS. Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: therapeutic Insights for Epilepsy. J Pharmacol Exp Ther. 2018;364(2):180–197. doi:10.1124/jpet.117.24467329142081
   PubMed Web of Science ®Google Scholar
• Butler KM, Moody OA, Schuler E, et al. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy. Brain. 2018;141(8):2392–2405. doi:10.1093/brain/awy17129961870
   PubMed Web of Science ®Google Scholar
• May P, Girard S, Harrer M, et al. Rare coding variants in genes encoding GABA(A) receptors in genetic generalised epilepsies: an exome-based case-control study. Lancet Neurol. 2018;17(8):699–708. doi:10.1016/s1474-4422(18)30215-130033060
   PubMed Web of Science ®Google Scholar
• Dörfler P, Busslinger M. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. EMBO j. 1996;15(8):1971–1982. doi:10.1002/j.1460-2075.1996.tb00548.x8617244
   PubMed Web of Science ®Google Scholar
• Reidy KJ, Rosenblum ND. Cell and molecular biology of kidney development. Semin Nephrol. 2009;29(4):321–337. doi:10.1016/j.semnephrol.2009.03.00919615554
   PubMed Web of Science ®Google Scholar
• Bouchard M, Grote D, Craven SE, Sun Q, Steinlein P, Busslinger M. Identification of Pax2-regulated genes by expression profiling of the mid-hindbrain organizer region. Development. 2005;132(11):2633–2643. doi:10.1242/dev.0183315872005
   PubMed Web of Science ®Google Scholar
• Hnoonual A, Sripo T, Limprasert P. Whole-exome sequencing identifies a novel heterozygous missense variant of the EN2 gene in two unrelated patients with autism spectrum disorder. Psychiatr Genet. 2016;26(6):297–301. doi:10.1097/ypg.000000000000015327755371
   PubMed Web of Science ®Google Scholar
• Boschian C, Messina A, Bozza A, et al. Impaired Neuronal Differentiation of Neural Stem Cells Lacking the Engrailed-2 Gene. Neuroscience. 2018;386:137–149. doi:10.1016/j.neuroscience.2018.06.03229964155
   PubMed Web of Science ®Google Scholar
• Snijders Blok L, Kleefstra T, Venselaar H, et al. De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder. Am J Hum Genet. 2019;105(2):403–412. doi:10.1016/j.ajhg.2019.06.00731303265
   PubMed Web of Science ®Google Scholar
• Zhang HS, Yan B, Li XB, et al. PAX2 protein induces expression of cyclin D1 through activating AP-1 protein and promotes proliferation of colon cancer cells. J Biol Chem. 2012;287(53):44164–44172. doi:10.1074/jbc.M112.40152123135283
   PubMed Web of Science ®Google Scholar
• Torban E, Dziarmaga A, Iglesias D, et al. PAX2 activates WNT4 expression during mammalian kidney development. J Biol Chem. 2006;281(18):12705–12712. doi:10.1074/jbc.M51318120016368682
   PubMed Web of Science ®Google Scholar
• Saifudeen Z, Liu J, Dipp S, et al. A p53-Pax2 pathway in kidney development: implications for nephrogenesis. PLoS One. 2012;7(9):e44869. doi:10.1371/journal.pone.004486922984579
   PubMed Web of Science ®Google Scholar
• Xu B, Zeng DQ, Wu Y, et al. Tumor suppressor menin represses paired box gene 2 expression via Wilms tumor suppressor protein-polycomb group complex. J Biol Chem. 2011;286(16):13937–13944. doi:10.1074/jbc.M110.19783021378168
   PubMed Web of Science ®Google Scholar
• Zeng K, Wu Y, Wang C, et al. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription. Cancer Sci. 2020;111(6):2062–2077. doi:10.1111/cas.1441332279431
   PubMed Web of Science ®Google Scholar
• Liu P, Gao Y, Huan J, et al. Upregulation of PAX2 promotes the metastasis of esophageal cancer through interleukin-5. Cell Physiol Biochem. 2015;35(2):740–754. doi:10.1159/00036973425613757
   PubMedGoogle Scholar